Jade Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	903	956	1,511	628	724	288
Market Cap Growth	298.67%	-36.76%	140.56%	-13.27%	151.70%	-
Enterprise Value	593.01	708.71	1,619	506.09	595.87	120.81
Last Close Price	15.22	15.43	92.75	792.05	1025.50	412.65
PB Ratio	2.53	7295.48	-	5.74	5.72	1.67
P/TBV Ratio	-2011.98	3693.77	-	5.44	5.66	0.84
Debt / Equity Ratio	-2.00	5.53	53800.00	0.00	0.01	0.00
Net Debt / Equity Ratio	751.56	-1885.47	-	-1.11	-1.01	-0.97
Net Debt / EBITDA Ratio	1.91	2.18	-1.45	1.50	2.41	7.25
Net Debt / FCF Ratio	2.19	2.60	-1.51	2.14	3.26	6.05
Quick Ratio	11.49	14.98	0	6.94	16.61	65.64
Current Ratio	11.49	21.09	5.81	7.04	16.90	68.37
Return on Equity (ROE)	124028.00%	-191594.00%	-127.22%	-63.95%	-34.44%	-26.19%
Return on Assets (ROA)	-39.91%	-53.71%	-74.57%	-62.02%	-34.29%	-25.57%
Return on Invested Capital (ROIC)	-176.41%	-153.99%	-228.00%	-2090.03%	-1084.78%	-812.31%
Return on Capital Employed (ROCE)	-42.39%	-57.63%	-87.46%	-68.61%	-35.45%	-26.20%
Buyback Yield / Dilution	-	-3740.15%	-8.55%	-7.60%	-99.06%	-4975.16%
Total Shareholder Return	-	-3740.15%	-8.55%	-7.60%	-99.06%	-4975.16%

SEC Filings: 10-K · 10-Q